G Medical Innovations Holdings Ltd
GMVD · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $4,420 | $5,058 | $4,900 | $5,526 |
| % Growth | -12.6% | 3.2% | -11.3% | – |
| Cost of Goods Sold | $3,636 | $3,556 | $4,233 | $5,749 |
| Gross Profit | $784 | $1,502 | $667 | -$223 |
| % Margin | 17.7% | 29.7% | 13.6% | -4% |
| R&D Expenses | $2,292 | $1,680 | $1,315 | $2,552 |
| G&A Expenses | $24,856 | $9,005 | $7,661 | $10,004 |
| SG&A Expenses | $24,856 | $9,005 | $7,661 | $10,004 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $1,046 | $854 | $3,695 | $0 |
| Operating Expenses | $28,194 | $11,539 | $12,671 | $12,556 |
| Operating Income | -$27,410 | -$10,037 | -$12,004 | -$14,526 |
| % Margin | -620.1% | -198.4% | -245% | -262.9% |
| Other Income/Exp. Net | $13,468 | -$3,622 | -$702 | -$3,584 |
| Pre-Tax Income | -$13,942 | -$14,891 | -$12,706 | -$16,363 |
| Tax Expense | $16 | -$3 | -$18 | -$857 |
| Net Income | -$13,958 | -$14,888 | -$12,688 | -$15,506 |
| % Margin | -315.8% | -294.3% | -258.9% | -280.6% |
| EPS | 0 | -45.89 | -60.4 | -7 |
| % Growth | 100% | 24% | -762.9% | – |
| EPS Diluted | 0 | -45.89 | -60.4 | -7 |
| Weighted Avg Shares Out | 0 | 324 | 210 | 2,214 |
| Weighted Avg Shares Out Dil | 0 | 324 | 210 | 2,214 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $870 | $344 | $263 |
| Interest Expense | $0 | $4,492 | $750 | $3,847 |
| Depreciation & Amortization | -$10,341 | $1,000 | $3,606 | $2,010 |
| EBITDA | -$37,751 | -$9,037 | -$8,398 | -$12,516 |
| % Margin | -854.1% | -178.7% | -171.4% | -226.5% |